BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 187218)

  • 1. Inhibition of estrogen-induced increases in uterine guanosine 3',5'-cyclic monophosphate levels by inhibitors of protein and RNA synthesis.
    Nicol SE; Goldberg ND
    Biochemistry; 1976 Dec; 15(25):5490-6. PubMed ID: 187218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-related increases in uterine guanosine 3':5'-cyclic momophosphate levels.
    Kuehl FA; Ham EA; Zanetti ME; Sanford CH; Nicol SE; Goldberg ND
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1866-70. PubMed ID: 4365763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of RNA synthesis in the estrogen induction of a specific uterine protein.
    DeAngelo AB; Gorski J
    Proc Natl Acad Sci U S A; 1970 Jul; 66(3):693-700. PubMed ID: 5269235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediation by epidermal growth factor of the estradiol-induced increase in cyclic guanosine 3',5'-monophosphate content in the rat uterus.
    Galand P; Rooryck J
    Endocrinology; 1996 May; 137(5):1932-7. PubMed ID: 8612533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 5-aminolevulinic acid dose and estrogen on protoporphyrin IX concentrations in the rat uterus.
    Roy BN; Van Vugt DA; Weagle GE; Pottier RH; Reid RL
    J Soc Gynecol Investig; 1997; 4(1):40-6. PubMed ID: 9051633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic control mechanisms in mammalian systems. XV. Studies on the role of adenosine 3' ,5'-monophosphate in estrogen action on the uterus.
    Singhal RL; Lafreniere RT
    J Pharmacol Exp Ther; 1972 Jan; 180(1):86-97. PubMed ID: 4110809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-induced alterations in cyclic nucleotide and prostaglandin levels in target tissue.
    Kuehl FA; Zanetti ME; Cirillo VJ; Ham EA
    J Steroid Biochem; 1975 Jun; 6(6):1099-105. PubMed ID: 170459
    [No Abstract]   [Full Text] [Related]  

  • 8. Oestrogen-induced changes in uterine cGMP: relationship with other parameters of hormonal stimulation [proceedings].
    Flandroy L; Fastrez-Boute A; Galand P
    Arch Int Physiol Biochim; 1976 Dec; 84(5):1072-4. PubMed ID: 65997
    [No Abstract]   [Full Text] [Related]  

  • 9. Estrogen-directed synthesis of specific prostaglandins in uterus.
    Ham EA; Cirillo VJ; Zanetti ME; Kuehl FA
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1420-4. PubMed ID: 165507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in cGMP and cAMP content in the estrogen-stimulated rat uterus: temporal relationship with other parameters of hormonal stimulation.
    Flandroy L; Galand P
    J Cyclic Nucleotide Res; 1978 Apr; 4(2):145-58. PubMed ID: 207753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogen-induced increase in uterine cGMP content in vitro: effects of inhibitors of protein and RNA synthesis.
    Flandroy L; Galand P
    Mol Cell Endocrinol; 1982 Jan; 25(1):49-54. PubMed ID: 6175545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen effects on uterine metabolism: reversal by inhibitors of protein synthesis.
    Gorski J; Morgan MS
    Biochim Biophys Acta; 1967 Nov; 149(1):282-7. PubMed ID: 5582746
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of glucose-6-phosphate dehydrogenase activity in uterine tissue in organ culture.
    Keran EE; Barker KL
    Endocrinology; 1976 Nov; 99(5):1386-97. PubMed ID: 1086769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractoriness of the gravid rat uterus to tocolytic and biochemical effects of atrial natriuretic peptide.
    Potvin W; Varma DR
    Br J Pharmacol; 1990 Jun; 100(2):341-7. PubMed ID: 1974161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gap junction modulation in rat uterus. III. Structure-activity relationships of estrogen receptor-binding ligands on myometrial and serosal cells.
    Burghardt RC; Gaddy-Kurten D; Burghardt RL; Kurten RC; Mitchell PA
    Biol Reprod; 1987 Apr; 36(3):741-51. PubMed ID: 3593845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of estrogens on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid.
    DiAugustine RP; Petrusz P; Bell GI; Brown CF; Korach KS; McLachlan JA; Teng CT
    Endocrinology; 1988 Jun; 122(6):2355-63. PubMed ID: 3286224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that 17alpha-estradiol is biologically active in the uterine tissue: antiuterotonic and antiuterotrophic action.
    Perusquía M; Navarrete E
    Reprod Biol Endocrinol; 2005 Jul; 3():30. PubMed ID: 16042770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17 beta-estradiol: inducer of uterine hexokinase.
    Valadares JR; Singhal RL; Parulekar MR
    Science; 1968 Mar; 159(3818):990-1. PubMed ID: 4229839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that spontaneous contractile activity in the rat myometrium is not inhibited by NO-mediated increases in tissue levels of cyclic GMP.
    Hennan JK; Diamond J
    Br J Pharmacol; 1998 Mar; 123(5):959-67. PubMed ID: 9535026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein selectively inhibits estrogen-induced cell proliferation and other responses to hormone stimulation in the prepubertal rat uterus.
    Gaete L; Tchernitchin AN; Bustamante R; Villena J; Lemus I; Gidekel M; Cabrera G; Carrillo O
    J Med Food; 2011 Dec; 14(12):1597-603. PubMed ID: 21612459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.